Login
$DGX
$262.21 +$0.00 (0.0%) After hours

$DGX 8-K/A SEC Filings

Filed On Filing
01 Jul 2022 8-K/A: Departure/Election of Directors or Officers; Compensation

In connection with his retirement, Mr. Rusckowski’s existing employment agreement with the company will not be renewed, pursuant to notice given in accordance with the employment agreement on June 29, 2022. Mr. Rusckowski’s compensation ...

01 Mar 2022 8-K/A: Departure/Election of Directors or Officers; Compensation

On February 24, 2022, the Compensation Committee of the Board of Directors of the Company approved the following compensation for Mr. Davis for 2022: an annual base salary (“Base Salary”) of $800,000; a target cash incentive compensation...

19 Aug 2021 8-K/A: Departure/Election of Directors or Officers; Compensation

SECAUCUS, N.J., August 17, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Ms. Tracey C. Doi to serve as a direc...

17 May 2019 8-K/A: Departure/Election of Directors or Officers; Compensation

As previously reported by Quest Diagnostics Incorporated (the “Company”) on a Current Report on Form 8-K filed with the Securities and Exchange Commission on April 1, 2019 (the “Initial Form 8-K”), the Company announced that Michael J. D...

21 Aug 2017 8-K/A: Submission of Matters to a Vote of Security Holders

At the 2017 Annual Meeting of Stockholders of the Company (the “Meeting”), a majority of votes cast with respect to the proposal to recommend the frequency of the advisory vote on executive compensation were cast in favor of conducting s...

29 Feb 2012 8-K/A: Departure/Election of Directors or Officers; Compensation

Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

17 Aug 2011 8-K/A: Submission of Matters to a Vote of Security Holders

In light of the voting results concerning the frequency with which stockholders will be provided an advisory vote on executive compensation that were delivered at the Company’s 2011 annual meeting of stockholders, the Company’s board of ...

13 Aug 2007 8-K/A: Completion of Acquisition or Disposition of Assets

The Board of Directors and Stockholder of AmeriPath Group Holdings, Inc. and Subsidiaries:

11 Jul 2006 8-K/A: Costs Associated with Exit or Disposal Activities; Material Impairments

The following information is filed pursuant to “Item 2.05 Costs Associated with Exit or Disposal Activities,” and amends the Form 8-K filed by the Company on April 20, 2006.

17 Jan 2006 8-K/A: Completion of Acquisition or Disposition of Assets

We have audited the accompanying consolidated balance sheets of LabOne, Inc. and subsidiaries (the Company) as of December 31, 2004 and 2003, and the related consolidated statements of operations, stockholders’ equity and comprehensive i...

20 Nov 2003 8-K/A: Financial Statements and Exhibits

Quest Diagnostics Incorporated Unaudited Pro Forma Combined Financial Statements

01 May 2003 8-K/A: Financial Statements and Exhibits

Quest Diagnostics Incorporated Unaudited Pro Forma Combined Financial Statements

01 Nov 1999 8-K/A: Financial Statements and Exhibits

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 --------------------------------------------------------------------------------

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support